References
Gelfand EW (1989) The use of intravenous immune globulin in collagen vascular disorders: A potentially new modality of therapy. J Allergy Clin Immunol 84:613–616
Van der Meché FGA, Schmitz PIM, Dutch Guillain-Barre Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain Barrè syndrome. N Engl J Med 326:1123–1129
Achiron A, Gabbay U, Gilad R et al (1998) Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 50:398–402
Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsingremitting multiple sclerosis. Lancet 349:589–593
Cook SD, Troiano R, Rohowsky-Kochin C et al (1992) Intravenous gamma globulin in progressive MS. Acta Neurol Scand 86:171–175
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444–1452
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salemi, G., Manfrè, L., Monaco, S. et al. Intravenous gammaglobulin treatment in chronic progressive multiple sclerosis. Ital J Neuro Sci 19, 331–332 (1998). https://doi.org/10.1007/BF00713862
Issue Date:
DOI: https://doi.org/10.1007/BF00713862